ctrl K

Watchlist Price Alert

Aridis Pharmaceuticals In... (ARDS)

OTC: ARDS · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 01, 2025, 9:51 AM

Aridis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	1M	1.02M	2.76M	860K	2.27M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	1.93M
Gross Profit	n/a	n/a	1M	1.02M	2.76M	860K	342K
Operating Income	-29.99M	-43.71M	-22.4M	-29.09M	-24.12M	-19.74M	-7.88M
Interest Income	n/a	n/a	77K	357K	n/a	234K	n/a
Pretax Income	-30.37M	-43.19M	-22.33M	-29.68M	-22.11M	-24.66M	-8.42M
Net Income	-30.75M	-42.28M	-21.92M	-28.99M	-22.11M	-24.66M	-8.42M
Selling & General & Admin	7.16M	7.31M	6.45M	6.03M	3.87M	3.16M	1.97M
Research & Development	25.92M	37.94M	16.96M	24.08M	23M	17.44M	6.26M
Other Expenses	-3.09M	-1.53M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	29.99M	43.71M	23.4M	30.11M	26.87M	20.6M	8.23M
Interest Expense	378K	-245K	n/a	n/a	420K	n/a	366K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	29.99M	43.71M	23.4M	30.11M	26.87M	20.6M	10.15M
Income Tax Expense	378K	-912K	-414K	-695K	2.43M	4.92M	538K
Shares Outstanding (Basic)	18.78M	12.29M	9.17M	8.46M	3.15M	7.89M	7.89M
Shares Outstanding (Diluted)	18.78M	12.29M	9.17M	8.46M	3.15M	7.89M	7.89M
EPS (Basic)	-1.64	-3.44	-2.39	-3.43	-7.02	-3.12	-1.07
EPS (Diluted)	-1.64	-3.44	-2.39	-3.43	-7.02	-3.12	-1.07
EBITDA	-29.51M	-44.43M	-22.06M	-28.75M	-23.83M	-19.68M	-7.86M
EBIT	n/a	-43.44M	-22.4M	-29.09M	-24.12M	-19.74M	-7.88M
Depreciation & Amortization	487K	-722K	337K	338K	283K	62K	23K